Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.39B 1.21B 1.12B 1.03B 1.95B 132B 1.97B 13.21B 5.18B 66.23B 5.23B 5.11B 219B P/E 2026 *
28x
P/E 2027 * 14.4x
Enterprise Value 2.88B 2.5B 2.33B 2.14B 4.04B 274B 4.08B 27.34B 10.73B 137B 10.82B 10.58B 454B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.55x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day-1.59%
1 week+7.10%
Current month+6.07%
1 month-2.86%
3 months+33.59%
6 months+62.32%
Current year+42.19%
1 week 16.24
Extreme 16.24
18.34
1 month 16.04
Extreme 16.04
20.49
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.65
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
3/7/26 Tax

Chief Financial Officer

-5,226 0.0067%
1/7/26 Free

Executive/Senior Manager

5,590 0.0072%
1/7/26 Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
-1.59%+7.10%+38.73%-61.13% 1.39B
-0.76%-3.10%-19.93%-3.50% 182B
-0.73%-2.26%-4.58%+0.99% 110B
+4.07%-0.10%+8.88%+70.60% 59.59B
-0.10%+9.35%+43.37%+59.19% 55.04B
-0.61%+0.09%-4.71%-38.76% 46.87B
-16.29%-11.63% - - 35.55B
-4.87%+9.97%+9.50%-31.69% 32.81B
+0.44%+3.64%+46.42%-7.64% 24.54B
-1.50%-2.49%+2.28%+1.23% 22.69B
Average -2.24%+2.66%+13.33%-1.19% 57.13B
Weighted average by Cap. -1.41%+1.52%+0.21%+7.16%

Financials

2026 *2027 *
Net sales 1.67B 1.45B 1.35B 1.24B 2.35B 159B 2.37B 15.89B 6.23B 79.66B 6.29B 6.15B 264B 1.73B 1.5B 1.4B 1.28B 2.42B 164B 2.45B 16.39B 6.43B 82.21B 6.49B 6.35B 272B
Net income 42.03M 36.4M 33.94M 31.21M 58.92M 4B 59.58M 399M 157M 2B 158M 154M 6.62B 78.69M 68.16M 63.53M 58.43M 110M 7.48B 112M 747M 293M 3.74B 296M 289M 12.4B
Net Debt 1.49B 1.29B 1.2B 1.11B 2.09B 142B 2.11B 14.13B 5.55B 70.86B 5.59B 5.47B 235B 1.28B 1.11B 1.04B 954M 1.8B 122B 1.82B 12.19B 4.78B 61.13B 4.83B 4.72B 202B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
06/08/26 US$17.63 -1.51% 226,486
04/08/26 US$17.90 +0.11% 748,606
03/08/26 US$17.88 +7.39% 1,278,776
31/07/26 US$16.65 -2.75% 935,088
30/07/26 US$17.12 +3.82% 1,707,650
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
17.90USD
Average target price
19.56USD
Spread / Average Target
+9.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock